All Women with Multiple Sclerosis Should Start Hormone Replacement Therapy at Menopause Unless Contraindicated: Yes
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Itoh N, Itoh Y, Meyer C, Suen T, Cortez-Delgado D, Lomeli M
. Estrogen receptor beta in astrocytes modulates cognitive function in mid-age female mice. Nat Commun. 2023; 14(1):6044.
PMC: 10533869.
DOI: 10.1038/s41467-023-41723-7.
View
2.
MacKenzie-Graham A, Brook J, Kurth F, Itoh Y, Meyer C, Montag M
. Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry. Brain Behav. 2018; 8(9):e01086.
PMC: 6160650.
DOI: 10.1002/brb3.1086.
View
3.
Voskuhl R, Wang H, Wu T, Sicotte N, Nakamura K, Kurth F
. Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2015; 15(1):35-46.
DOI: 10.1016/S1474-4422(15)00322-1.
View
4.
Kim R, Mangu D, Hoffman A, Kavosh R, Jung E, Itoh N
. Oestrogen receptor β ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis. Brain. 2017; 141(1):132-147.
PMC: 5837360.
DOI: 10.1093/brain/awx315.
View
5.
Voskuhl R, Itoh Y
. The X factor in neurodegeneration. J Exp Med. 2022; 219(12).
PMC: 9641640.
DOI: 10.1084/jem.20211488.
View